Combined therapies increase side effects for patients with advanced breast cancer

Patients with advanced breast cancer who are treated with a combination of drugs that target specific molecules important for cancer development and also the hormones that are driving it are at increased risk of suffering adverse side effects. In new research presented at the Advanced Breast Cancer Fourth International Consensus Conference (ABC 4), researchers have … Continue reading Combined therapies increase side effects for patients with advanced breast cancer

Advertisements

Thousands of melanoma patients in Europe have no access to new life saving drugs

Unacceptable inequalities in the availability and accessibility of new and effective cancer medications across Europe. Over 5000 patients with metastatic melanoma in Europe are denied access to new, life-saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen. Metastatic melanoma is an aggressive and deadly skin cancer. With innovative … Continue reading Thousands of melanoma patients in Europe have no access to new life saving drugs

Chemotherapy and exercise: The right dose of workout helps side effects

Researchers at the University of Rochester Wilmot Cancer Institute discovered something simple and inexpensive to reduce neuropathy in hands and feet due to chemotherapy - exercise. The study, involving more than 300 cancer patients, is to be presented this weekend and honored as a "Best of ASCO" among 5,800 abstracts at the world's largest gathering … Continue reading Chemotherapy and exercise: The right dose of workout helps side effects

Counseling patients at risk for cancer over the phone reduces costs and access burdens

Patients who receive results of genetic tests over the phone do not experience increased anxiety or depression. Delivering genetic test results to patients at risk for cancer-causing genetic mutations over the phone helps to ease cost and transportation burdens and, compared to receiving results in person, does not cause patients additional stress, according to a … Continue reading Counseling patients at risk for cancer over the phone reduces costs and access burdens

Hispanic and black young adult cancer patients more likely to die of their disease

Hispanic white and non-Hispanic black cancer patients between ages 15 and 29 may be more likely than same-aged white patients to die of their disease, according to a University of Colorado Cancer Center study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2016. The finding is partially but not wholly explained by … Continue reading Hispanic and black young adult cancer patients more likely to die of their disease

Chemoradiation may increase survival for a subset of elderly head and neck cancer patients

The addition of chemotherapy (CT) to radiation therapy (RT) improves survival rates among a subset of elderly head and neck cancer patients, specifically those ages 71 to 79 with low comorbidity scores and advanced disease stage, according to University of Colorado Cancer Center research presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium. While … Continue reading Chemoradiation may increase survival for a subset of elderly head and neck cancer patients

Why does tamoxifen work better in some women?

The anti-hormone therapy tamoxifen can reduce breast cancer recurrence by about half in women with hormone-sensitive breast cancer. But it works better in some women than others. Researchers are not sure why. "We do know that some tumors are inherently resistant to tamoxifen because of tumor genetic changes," says Daniel L. Hertz, Pharm.D., Ph.D., an … Continue reading Why does tamoxifen work better in some women?

Anti-androgen therapy improves survival for men with cancer recurrence after prostatectomy

Men with prostate cancer who haveĀ prostate-specific antigenĀ recurrence following radical prostatectomy have improved survival with radiotherapy and a long-term course of anti androgen therapy. It is well established that a rising serum prostate-specific antigen (PSA) level is an indication of cancer progression in men diagnosed with prostate cancer and treated with radical prostatectomy (RP). For these … Continue reading Anti-androgen therapy improves survival for men with cancer recurrence after prostatectomy

Gene therapy doubles survival in recurrent glioblastoma

An experimental gene therapy essentially doubled the overall survival of patients with recurrent glioblastoma compared to the current standard of care. Glioblastoma is an aggressive brain cancer that kills two-thirds of patients within five years. A patient's outlook with recurrence of the disease is considered to be weeks or months. CTRC medical oncologist Andrew J. … Continue reading Gene therapy doubles survival in recurrent glioblastoma

Patients with lowest body mass index have shortest survival in metastatic colorectal cancer treated with bevacizumab

Patients with the lowest body mass index (BMI) had the shortest overall survival in an analysis of bevacizumab studies in metastatic colorectal cancer (mCRC) presented for the first time at the ESMO 17th World Congress on Gastrointestinal Cancer 2015 in Barcelona. "There is good evidence that obesity increases the risk of getting colorectal cancer and … Continue reading Patients with lowest body mass index have shortest survival in metastatic colorectal cancer treated with bevacizumab